113 related articles for article (PubMed ID: 3490975)
1. In vitro activity of cefetamet (Ro 15-8074).
Mittermayer H
Eur J Clin Microbiol; 1986 Oct; 5(5):530-4. PubMed ID: 3490975
[No Abstract] [Full Text] [Related]
2. In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
Hohl P; Salfinger M; Kafader FM
Eur J Clin Microbiol; 1987 Aug; 6(4):487-8. PubMed ID: 3117539
[No Abstract] [Full Text] [Related]
3. In-vitro activity of Ro-15-8074, a new oral cephalosporin.
Peeters M; Piot P
J Antimicrob Chemother; 1985 Oct; 16(4):469-73. PubMed ID: 3877719
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of RO 15-8074 and RO 19-5247.
Valle T; Jalanko E; Scheinin L; Renkonen OV
Eur J Clin Microbiol; 1987 Apr; 6(2):167-9. PubMed ID: 3109897
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
Fass RJ; Helsel VL
Antimicrob Agents Chemother; 1986 Sep; 30(3):429-34. PubMed ID: 3777906
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial spectrum of Ro 15-8074/001, a new oral cephalosporin.
Thomas MG; Lang SD
Antimicrob Agents Chemother; 1986 May; 29(5):945-7. PubMed ID: 3729354
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of enterococci to beta-lactam antibiotics, co-trimoxazole, nitrofurantoin, tetracycline and doxycycline.
Grimm H
Arzneimittelforschung; 1983; 33(3):419-23. PubMed ID: 6603227
[TBL] [Abstract][Full Text] [Related]
8. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
Lebek G; Wiedmer E
Schweiz Med Wochenschr; 1971 Sep; 101(38):1385-90. PubMed ID: 4946735
[No Abstract] [Full Text] [Related]
9. Ro 15-8075 (cefetamet pivoxyl), a new oral cephalosporin: in vitro activity of the free acid Ro 15-8074 and regression line analyses.
Grimm K; Grimm H
Chemioterapia; 1987 Jun; 6(2 Suppl):84-7. PubMed ID: 3509540
[No Abstract] [Full Text] [Related]
10. Ro 13-9904 and GR 20263, two new cephalosporins with broad-spectrum activity: an in vitro comparison with other beta-lactam antibiotics.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1981 May; 7(5):515-20. PubMed ID: 6790506
[No Abstract] [Full Text] [Related]
11. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Forsgren A; Walder M
Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
[TBL] [Abstract][Full Text] [Related]
12. The newer antimicrobials.
Wong HB
J Singapore Paediatr Soc; 1985; 27(3-4):137-45. PubMed ID: 3879521
[No Abstract] [Full Text] [Related]
13. In-vitro comparative study of Lidaprim and co-trimoxazole.
Abdel-Messih EF; Suleiman MN; Baron JM
J Int Med Res; 1984; 12(3):219-20. PubMed ID: 6376211
[No Abstract] [Full Text] [Related]
14. In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
Kumar A; Kelly KJ
Chemotherapy; 1988; 34(1):30-5. PubMed ID: 3258232
[TBL] [Abstract][Full Text] [Related]
15. New applications of old antimicrobials.
Marks MI
Pediatr Ann; 1986 Jun; 15(6):434-5, 438-40. PubMed ID: 3523401
[No Abstract] [Full Text] [Related]
16. Surveillance study of resistance in Haemophilus species in Greece.
Kanellakopoulou K; Giamarellou H; Avlamis A
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):186-8. PubMed ID: 3134210
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Chau PY; Leung YK; Ng WW; Arnold K
Antimicrob Agents Chemother; 1987 Mar; 31(3):473-6. PubMed ID: 3579264
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
Doern GV; Chapin KC
Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
Segreti J; Kessler HA; Kapell KS; Trenholme GM
Antimicrob Agents Chemother; 1987 Jan; 31(1):100-1. PubMed ID: 2952061
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activities of trospectomycin, cefpodoxime, and second-generation cephalosporins against Haemophilus influenzae type b.
LiPuma JJ; Daley B; Stull TL
J Antimicrob Chemother; 1990 Apr; 25(4):535-9. PubMed ID: 2141018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
